Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2024-03-01 Declaration of Voting R…
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is very short (2747 characters) and explicitly states it is an 'RNS Number' announcement from the London Stock Exchange's news service. The content details the 'Total Voting Rights' as of a specific date (29 February 2024) pursuant to DTR 5.6.1, which is a regulatory disclosure requirement. This type of specific, short regulatory update that doesn't fit the definition of a full report (like 10-K or IR) or a specific event (like DIV or DIRS) is best classified under the general regulatory announcement category, RNS, as per the definitions and the 'Menu vs Meal' rule (it's an announcement of a regulatory status, not a comprehensive report).
2024-03-01 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject is a "Transaction in Own Shares" and details the purchase of ordinary shares by the company as part of a previously announced share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement referencing RNS as the news service of the London Stock Exchange confirms it is a regulatory announcement, but the specific content dictates the most precise classification is POS.
2024-02-22 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document is an official announcement identified by the 'RNS Number' and references to the London Stock Exchange and FCA. The core subject matter is the 'Transaction in Own Shares' (share buyback) conducted by Syncona Limited on February 20, 2024. This directly corresponds to the definition of a company reporting the repurchase or sale of its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document length is short (3243 chars), but it contains the full details of the transaction, not just an announcement that a report is attached, making POS more specific than RPA or RNS.
2024-02-21 English
Acquisition of Freeline Becomes Effective
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 7930D' and contains an announcement dated February 20, 2024, regarding the completion of an acquisition ('Acquisition of Freeline Becomes Effective'). It details the final steps of a Scheme of Arrangement, including shareholder entitlements, settlement dates, and the de-listing of ADSs. The closing section explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure—a formal, brief announcement of a significant corporate event distributed via the RNS system—fits the definition of a general regulatory announcement that doesn't fit a more specific category like 10-K, ER, or DIV. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-02-20 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states its purpose in the title section: "Transaction in Own Shares". It details the purchase of 100,000 ordinary shares by the company as part of a previously announced share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers company repurchases. The presence of the RNS Number and the closing statement referencing RNS confirms it is a regulatory announcement, but the specific content dictates the most precise code.
2024-02-20 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states 'Transaction in Own Shares' and details the purchase of 200,000 ordinary shares by the company as part of a share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The document is a formal announcement, likely filed via RNS, but the core subject matter is the share repurchase activity itself, making POS the most specific classification over the general RNS fallback.
2024-02-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.